Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1993-8-24
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0022-1899
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
168
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
515-6
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:8335999-Animals,
pubmed-meshheading:8335999-Antibodies, Monoclonal,
pubmed-meshheading:8335999-Antigens, CD4,
pubmed-meshheading:8335999-HIV Antibodies,
pubmed-meshheading:8335999-HIV Infections,
pubmed-meshheading:8335999-Humans,
pubmed-meshheading:8335999-Immunization, Passive,
pubmed-meshheading:8335999-Mice
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Monoclonal anti-CD4 as immunoprophylactic agents for human immunodeficiency virus infection.
|
| pubmed:publicationType |
Letter,
Research Support, U.S. Gov't, P.H.S.
|